Lorna MacLean

Lorna MacLean is a Team Leader at the Drug Discovery Unit, focusing on pharmacology, toxicology, and parasitology. Her research targets Trypanosoma cruzi (Chagas disease) and visceral leishmaniasis, emphasizing drug discovery and validation of parasitic enzymes like proteasomes and kinases.

• Key research areas:
  • Parasitic diseases (Chagas, Leishmaniasis)
  • Proteasome and kinase inhibitors
  • Drug discovery and development

Recent publications (2023–2025) highlight her work in

• Structural biology
• Medicinal chemistry
• High-throughput screening for antichagasic agents

Her contributions to target validation and inactivation techniques have been pivotal.

Scientific Awards

• DNDi Project of the Year 2023: Recognized for collaborative early discovery in Chagas disease
• Industry and Academic Collaboration Award 2023: Honored for interdisciplinary bioscience and kinetoplastid research partnerships